Lincoln Pharmaceuticals Limited (BOM:531633)
461.50
-4.15 (-0.89%)
At close: Jan 20, 2026
Lincoln Pharmaceuticals Market Cap
Lincoln Pharmaceuticals has a market cap or net worth of 9.08 billion as of January 23, 2026. Its market cap has decreased by -43.70% in one year.
Market Cap
9.08B
Enterprise Value
6.76B
Revenue
6.32B
Ranking
n/a
PE Ratio
11.35
Stock Price
461.50
Market Cap Chart
Since October 21, 2004, Lincoln Pharmaceuticals's market cap has increased from 138.90M to 9.08B, an increase of 6,435.03%. That is a compound annual growth rate of 21.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 23, 2026 | 9.08B | -6.21% |
| Dec 31, 2025 | 9.68B | -38.62% |
| Dec 31, 2024 | 15.77B | 29.24% |
| Dec 29, 2023 | 12.20B | 71.47% |
| Dec 30, 2022 | 7.12B | -0.74% |
| Dec 31, 2021 | 7.17B | 47.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TTK Healthcare | 14.14B |
| Kwality Pharmaceuticals | 11.22B |
| Syncom Formulations (India) | 11.05B |
| Venus Remedies | 9.84B |
| Fermenta Biotech | 9.59B |
| Bharat Parenterals | 7.63B |
| Anuh Pharma | 7.15B |
| Fredun Pharmaceuticals | 6.95B |